Structure-kinetic relationship studies of cannabinoid CB 2 receptor agonists reveal substituent-specific lipophilic effects on residence time
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 152, 129-142
Abstract
No abstract availableKeywords
Funding Information
- Netherlands Organisation for Scientific Research
This publication has 59 references indexed in Scilit:
- Slow receptor dissociation is not a key factor in the duration of action of inhaled long‐acting β2‐adrenoceptor agonistsBritish Journal of Pharmacology, 2011
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?Progress in Lipid Research, 2011
- Long‐lasting target binding and rebinding as mechanisms to prolongin vivodrug actionBritish Journal of Pharmacology, 2010
- Endocannabinoids and immune regulation☆Pharmacological Research, 2009
- Slow-Onset Inhibition of the FabI Enoyl Reductase from Francisella tularensis: Residence Time and in Vivo ActivityACS Chemical Biology, 2009
- Cannabinoid CB2receptors: a therapeutic target for the treatment of inflammatory and neuropathic painBritish Journal of Pharmacology, 2008
- Anandamide and Δ9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptorsJournal of Neuroimmunology, 2007
- Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M 3 receptorBritish Journal of Pharmacology, 2006
- A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analoguesProceedings of the National Academy of Sciences, 2006
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973